| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |